TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14971531

Group type: EXPERIMENTAL
Intervention: Tramadol SR 100 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 11145094

Group type: EXPERIMENTAL
Intervention: Daclizumab
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Basiliximab
Number of subjects: 4

Group type: COMPARATOR
Intervention: Immunosuppressive regimen (cyclosporin and prednisone) with daclizumab or basiliximab
Number of subjects: 4
Study: 8799661

Group type: EXPERIMENTAL
Intervention: Semmes-Weinstein monofilaments
Number of subjects: 1001

Group type: COMPARATOR
Intervention: Biothesiometer
Number of subjects: 1001

Group type: COMPARATOR
Intervention: Palpation of pedal pulses
Number of subjects: 1001
Study: 1634645

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Metoprolol (200 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Chlorthalidone (50 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Verapamil (240 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Atenolol and Chlorthalidone combination (100 mg and 50 mg)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 6695009

Group type: EXPERIMENTAL
Intervention: Aerobic conditioning
Number of subjects: 45

Group type: COMPARATOR
Intervention: Dietary educational sessions
Number of subjects: 45
Study: 31204832

Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy modified for stalking offenders (DBT-S)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Cognitive-behavioral anger management intervention
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Both interventions (DBT-S and anger management)
Number of subjects: 109
Study: 27861708

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D3 100,000 IU monthly
Number of subjects: 107

Group type: COMPARATOR
Intervention: Standard-dose vitamin D (placebo or 12,000 IU)
Number of subjects: 107
Study: 26463527

Group type: EXPERIMENTAL
Intervention: Infracostal access approach
Number of subjects: 83

Group type: COMPARATOR
Intervention: Supracostal access approach
Number of subjects: 83
Study: 23421576

Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Counseling‐As‐Usual (CAU)
Number of subjects: 194
Study: 21893379

Group type: EXPERIMENTAL
Intervention: Local mild hypothermia with IV rtPA (Group A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IV rtPA (Group B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional anti‐platelet aggregation (Group C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study: 20166442

Group type: EXPERIMENTAL
Intervention: Single-dose rosuvastatin 5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Single-dose rosuvastatin 10 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Single-dose rosuvastatin 20 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Multiple-dose rosuvastatin 5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Multiple-dose rosuvastatin 10 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Multiple-dose rosuvastatin 20 mg
Number of subjects: 12
Study: 17084264

Group type: EXPERIMENTAL
Intervention: 6 months exercise program (1 hour, 3 times/week)
Number of subjects: 67
Study: 15598476

Group type: EXPERIMENTAL
Intervention: Fluvastatin + Fenofibrate combination therapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Fluvastatin monotherapy
Number of subjects: 48
Study: 11759142

Group type: EXPERIMENTAL
Intervention: General anesthesia with interscalene block
Number of subjects: 52

Group type: COMPARATOR
Intervention: General anesthesia alone
Number of subjects: 52
Study: 9223543

Group type: EXPERIMENTAL
Intervention: Intrathecal neostigmine (50, 100 or 200 microg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous alfentanil
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intrathecal neostigmine + Intravenous alfentanil
Number of subjects: 40
Study: 7516376

Group type: COMPARATOR
Intervention: Terazosin, dosage not specified, administered once daily.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Terazosin, long-term treatment for more than two years.
Number of subjects: 0
Study: 3953352

Group type: EXPERIMENTAL
Intervention: Intravenous lorcainide (2 mg/kg bolus at 2 mg/min followed by 0.14 mg/min or 200 mg/24 hours)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Oral lorcainide (100 mg orally every 8 hours)
Number of subjects: 28
Study: 30182192

Group type: EXPERIMENTAL
Intervention: Baroreflex activation therapy (BAT) using the first-generation BAT device
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baroreflex activation therapy (BAT) using the Barostim Neo system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 26381036

Group type: COMPARATOR
Intervention: Intra-abdominal lavage with normal saline (Group 1)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Intra-abdominal lavage with gentamicin-clindamycin solution (Group 2)
Number of subjects: 104
Study: 25749596

Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 0
Study: 23378454

Group type: EXPERIMENTAL
Intervention: Vitamin A (25,000 IU/d retinyl palmitate)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 19769631

Group type: EXPERIMENTAL
Intervention: 5-Methoxypsoralen plus UVA (PUVA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Medium-dose UVA1
Number of subjects: 40
Study: 18729836

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy with sequential addition of drugs (noliprel, noliprel-forte, metoprolol, amlodipine) for 12-14 months
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy in patients with pronounced LVH (MMI 140 g/m2)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy in patients with minor initial diastolic dysfunction
Number of subjects: 99
Study: 15922556

Group type: EXPERIMENTAL
Intervention: Exercise training (3 times per week for 15 weeks)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study: 11823075

Group type: EXPERIMENTAL
Intervention: Additional stenting (using NIR stents)
Number of subjects: 437

Group type: COMPARATOR
Intervention: Balloon angioplasty alone (control group)
Number of subjects: 437
Study: 9656312

Group type: EXPERIMENTAL
Intervention: Physioacoustic treatment group
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study: 7644047

Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Phenytoin
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 59

Group type: COMPARATOR
Intervention: Nondrug baselines
Number of subjects: 59
Study: 2667779

Group type: EXPERIMENTAL
Intervention: Nalbuphine 0.1 mg.kg‐1 IV as premedication and isoflurane by inhalation
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline placebo and isoflurane by inhalation
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline placebo and halothane by inhalation
Number of subjects: 90

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 90
Study: 1087108

Group type: EXPERIMENTAL
Intervention: Surgical therapy (coronary bypass surgery)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 91
Study: 31756535

Group type: EXPERIMENTAL
Intervention: ATG prophylaxis
Number of subjects: 40
Study: 29080265

Group type: EXPERIMENTAL
Intervention: Autologous cord blood (ACB) infusion (1‐5 × 10^7 total nucleated cells per kilogram)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Autologous cord blood (ACB) infusion
Number of subjects: 63
Study: 26044471

Group type: EXPERIMENTAL
Intervention: Scheimpflug noncontact tonometry with daily disposable hydrogel contact lenses (Dailies-nelfilcon A)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Scheimpflug noncontact tonometry without hydrogel contact lenses
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Comparison of IOP measurements with and without CLs
Number of subjects: 88
Study: 24171680

Group type: EXPERIMENTAL
Intervention: HA-coated cups
Number of subjects: 100

Group type: COMPARATOR
Intervention: Porous-coated cups
Number of subjects: 100
Study: 20082240

Group type: EXPERIMENTAL
Intervention: Sodium oxybate (SXB)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 48
Study: 19114582

Group type: EXPERIMENTAL
Intervention: STEPS (Schizophrenia Treatment and Education Programs)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 57
Study: 16460384

Group type: EXPERIMENTAL
Intervention: Intervention (dementia care management program)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 232
Study: 15269000

Group type: EXPERIMENTAL
Intervention: Mobility methods requiring more gross motor control during the first assessment interval.
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Mobility methods requiring less gross motor control during the second assessment interval.
Number of subjects: 62
Study: 11097131

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) infusion (mean dose 2.4 +/- 0.9 mg/h), n = 33
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (0.9% sodium chloride), n = 15
Number of subjects: 48
Study: 9039716

Group type: EXPERIMENTAL
Intervention: 12 micrograms formoterol
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 400 micrograms salbutamol
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 1314632

Group type: COMPARATOR
Intervention: CDE (cyclophosphamide/doxorubicin/etoposide)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: IMP (carboplatin 400 mg/m2 + ifosfamide 5 g/m2)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: VP (vincristine twice 2 mg)
Number of subjects: 178
Study: 3850859

Group type: EXPERIMENTAL
Intervention: Transparent polyurethane (TP) dressings
Number of subjects: 737

Group type: COMPARATOR
Intervention: Dry gauze (DG) dressings
Number of subjects: 737
Study: 30183764

Group type: EXPERIMENTAL
Intervention: Children in school
Number of subjects: 534

Group type: COMPARATOR
Intervention: Children not in school
Number of subjects: 534
Study: 29137655

Group type: EXPERIMENTAL
Intervention: CT + Memory Support
Number of subjects: 178

Group type: COMPARATOR
Intervention: CT-as-usual
Number of subjects: 178
Study: 26671958

Group type: EXPERIMENTAL
Intervention: Ebola vaccine efficacy trial starting after 1 August
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Gradual recruitment in the trial
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Exclusion of early cases in either arm of the trial
Number of subjects: 100000
Study: 22505056

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 14

Group type: COMPARATOR
Intervention: Resistance exercise
Number of subjects: 14
Study: 21940973

Group type: EXPERIMENTAL
Intervention: Intraventricular recombinant tissue-type plasminogen activator
Number of subjects: 0
Study: 18470741

Group type: EXPERIMENTAL
Intervention: Panic attack-PTSD model
Number of subjects: 114

Group type: COMPARATOR
Intervention: Cognitive behavioural therapy
Number of subjects: 114
Study: 17157120

Group type: EXPERIMENTAL
Intervention: Human insulin 70/30
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Insulin lispro 75/25
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Insulin lispro 50/50
Number of subjects: 23

Group type: COMPARATOR
Intervention: Healthy controls (no treatment)
Number of subjects: 23
Study: 14624083

Group type: EXPERIMENTAL
Intervention: Active intervention (frequent active cervical rotation, assessment and treatment according to McKenzie's principles)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Active intervention (early initiation within 96 hours)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Standard intervention (initial rest, soft collar, gradual self-mobilization)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Delayed active intervention (initiated 14 days post-collision)
Number of subjects: 97
Study: 10844834

Group type: EXPERIMENTAL
Intervention: Cisatracurium infusion
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Rocuronium infusion
Number of subjects: 17
Study: 8852235

Group type: EXPERIMENTAL
Intervention: Occupation based health and fitness program
Number of subjects: 1504

Group type: COMPARATOR
Intervention: Usual training (Control)
Number of subjects: 1504
Study: 1320920

Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen (median duration of 60 months)
Number of subjects: 747
Study: 6730581

Group type: EXPERIMENTAL
Intervention: Metabolic basic diet enriched by polyene fatty acids
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Metabolic basic diet rich in polyene fatty acids
Number of subjects: 77
Study: 2870315

Group type: EXPERIMENTAL
Intervention: Local tetrachlorodecaoxygen anion complex (TCDO)
Number of subjects: 271

Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 271
Study: 29378515

Group type: EXPERIMENTAL
Intervention: Computerized cognitive training (FBT)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 15-min brisk walk followed by computerized cognitive training (Ex-FBT)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Active control (BAT) - combination of educational classes, sham cognitive training, and balanced and tone exercises
Number of subjects: 3
Study: 27517680

Group type: EXPERIMENTAL
Intervention: Fast-track surgery (FTS)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Traditional group
Number of subjects: 230
Study: 25784665

Group type: EXPERIMENTAL
Intervention: GLP-1 (1.2 pmol/kg/min) during hyperglycemia (∼12 mmol/L)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo during hyperglycemia (∼12 mmol/L)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: GLP-1 (1.2 pmol/kg/min) during euglycemia (∼6 mmol/L)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo during euglycemia (∼6 mmol/L)
Number of subjects: 10
Study: 23833850

Group type: EXPERIMENTAL
Intervention: Propofol total intravenous anesthesia (TIVA)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Desflurane-thiopental anesthesia
Number of subjects: 36
Study: 21122265

Group type: EXPERIMENTAL
Intervention: 6-week traditional exercise programme with supplementary whole-body vibration (WBV)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group performing the same physical activity programme without vibration training
Number of subjects: 30
Study: 18254806

Group type: EXPERIMENTAL
Intervention: Folic acid- and creatine-containing formulation
Number of subjects: 0
Study: 16361300

Group type: EXPERIMENTAL
Intervention: Parecoxib 40 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 14635469

Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Terbutaline (0.5 mg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Loratadine + Terbutaline
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 10953120

Group type: EXPERIMENTAL
Intervention: Double-J stent
Number of subjects: 670

Group type: COMPARATOR
Intervention: No stenting
Number of subjects: 670
Study: 9208508

Group type: EXPERIMENTAL
Intervention: Boosting doses of rabies vaccine
Number of subjects: 91

Group type: COMPARATOR
Intervention: 5-doses of rabies vaccine
Number of subjects: 91
Study: 1469179

Group type: EXPERIMENTAL
Intervention: Blind brush (BB) sampling
Number of subjects: 37

Group type: COMPARATOR
Intervention: Plugged telescoping catheter via fiberoptic bronchoscopy (PTC‐FB) sampling
Number of subjects: 37
Study: 6378354

Group type: EXPERIMENTAL
Intervention: Transfer Factor (TF)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 171
Study: 31067999

Group type: EXPERIMENTAL
Intervention: Injection site cooling
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Injection site warming
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (no warming or cooling)
Number of subjects: 14
Study: 28612500

Group type: EXPERIMENTAL
Intervention: Image J software for measuring ulcer area
Number of subjects: 31
Study: 26494609

Group type: EXPERIMENTAL
Intervention: Pedometer use and class competition over 12 weeks
Number of subjects: 1162
Study: 23378247

Group type: EXPERIMENTAL
Intervention: Group A (maintain two train-of-four (TOF) counts)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Group B (maintain a T(1)/Tc of 0.5)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Group C (maintain a T(2)/Tc of 0.5)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Group D (no NMB)
Number of subjects: 120
Study: 22005159

Group type: EXPERIMENTAL
Intervention: Ho:YAG laser urethrotomy (15 W; 1,200‐1,400 mJ; 8‐12 Hz)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Cold-knife urethrotomy
Number of subjects: 51
Study: 20027435

Group type: EXPERIMENTAL
Intervention: Cold lateral and warm vertical condensation of gutta-percha with Sealapex or Diaket sealers, post space prepared either individually or simultaneously.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (positive and negative controls).
Number of subjects: 64
Study: 17085633

Group type: EXPERIMENTAL
Intervention: Behavioral sleep intervention (5-week manualized intervention)
Number of subjects: 3
Study: 14751338

Group type: EXPERIMENTAL
Intervention: Mepartricin (40 mg daily)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 15321608

Group type: EXPERIMENTAL
Intervention: Supine wedged position
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lateral position
Number of subjects: 40
Study: 9555600

Group type: EXPERIMENTAL
Intervention: Triazolam (0.1875, 0.375, and 0.5625 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Zolpidem (7.5, 15, and 22.5 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Quazepam (15, 30, and 45 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 7912819

Group type: EXPERIMENTAL
Intervention: Amisulpride (AMI) 50 mg for 2 weeks, then 100 mg for 4 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fluphenazine (FLU) 2 mg for 2 weeks, then 4 mg for 4 weeks
Number of subjects: 40
Study: 2692153

Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 121

Group type: COMPARATOR
Intervention: Amoxicillin
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Ofloxacin (for atypical pneumonias and opportunistic infections)
Number of subjects: 121
Study: 790549

Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31789457

Group type: EXPERIMENTAL
Intervention: Thread therapy (PLLA) combined with minoxidil
Number of subjects: 27

Group type: COMPARATOR
Intervention: Minoxidil alone
Number of subjects: 27
Study: 30805623

Group type: EXPERIMENTAL
Intervention: Wheat DDGS diet (300 g/kg)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Wheat DDGS diet with xylanase (2,500 U/kg)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control diet (DDGS free)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control diet with xylanase (2,500 U/kg)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Wheat DDGS diet
Number of subjects: 320
Study: 26961522

Group type: EXPERIMENTAL
Intervention: High-viscosity glass-ionomer sealants
Number of subjects: 157

Group type: COMPARATOR
Intervention: Glass-carbomer sealants
Number of subjects: 157

Group type: COMPARATOR
Intervention: Resin sealants
Number of subjects: 157
Study: 26039907

Group type: EXPERIMENTAL
Intervention: Triclosan slurry
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control slurry
Number of subjects: 26
Study: 21949091

Group type: EXPERIMENTAL
Intervention: Individualized caregiver training program
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (information about community-based resources)
Number of subjects: 120
Study: 21719636

Group type: EXPERIMENTAL
Intervention: Coping With and Caring for Infants With Special Needs (COPCA)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Traditional infant physical therapy (TIP)
Number of subjects: 46
Study: 19704173

Group type: EXPERIMENTAL
Intervention: Intravenous ganciclovir
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Oral valganciclovir
Number of subjects: 9

Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Persistent viral load at day 21
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Confirmed ganciclovir resistance mutation
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Patients with confirmed CMV resistance mutations
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Confirmed ganciclovir-resistant UL97 mutants
Number of subjects: 9
Study: 16395750

Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone with rapid tapering (medrol dose-pack)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Triamcinolone 100 mg, given intramuscularly
Number of subjects: 50
Study: 15684846

Group type: EXPERIMENTAL
Intervention: Combined modality treatment consisting of aromatherapy, footsoak, and reflexology
Number of subjects: 20
Study: 11514044

Group type: EXPERIMENTAL
Intervention: Cognitive training interventions (memory, reasoning, and speed of information processing)
Number of subjects: 2832
Study: 9414079

Group type: EXPERIMENTAL
Intervention: Carbohydrate meal three hours before exercise and a carbohydrate‐electrolyte solution during exercise (M + C)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Carbohydrate‐electrolyte solution during exercise (P + C)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo three hours before exercise and placebo during exercise (P + P)
Number of subjects: 10
Study: 8119423

Group type: EXPERIMENTAL
Intervention: Subconjunctival injection of betamethasone (Betnesol, Glaxo)
Number of subjects: 246
Study: 3311690

Group type: EXPERIMENTAL
Intervention: 40 mg of famotidine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6